1SchmittCA LoweS.Apoptosis and therapy[J].J Pathol,1999,187:127-137.
2Subbarayan M,Hafeli UO,Feyes DK,et al.A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy[J].J Nucl Med,2003,44(4):650 -656.
3Tait JF,Smith C,Blankenberg FG.Structural requirements for in vivo detection of cell death with 99mTc-annexin V[J].J Nucl Med,2005,46(5):807 -815.
2Kerr JF,Winterford CM,Harmon BV.Apoptosisi:Its significance in cancer and cancer therapy.Cancer,1994,73(8):2013-2026
3Lahorte CM,Vanderheyden JL,Steinmetz N,et al.Apoptosis-detecting radioligands:current state of the art and future perspectives.Eur J Nucl Med Mol Imaging,2004,31:887-919
4Boersma HH,Kietselaer BL,Stolk LM,et al.Past,present,and future of annexin A5:from protein discovery to clinical applications.J Nucl Med,2005,46(12):2035-2050
5Van Heerde WL,de Groot PG.Reutelingsperger CPM.The complexity of the phospholipid binding protein annexin V.Thromb Haemost,1995,73:172-179
6Vermeersch H,Ham H,Rottey S,et al.Intraobserver,interobserver,and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma.Cancer Biother Radiopharm,2004,19(2):205-210
7Kartachova M,Haas RL,Olmos RA,et al.In vivo imaging of apoptosis by ^99mTc-annexin V scintigraphy:visual analysis in relation to treatment response.Radiother Oncol,2004,72(3):333-339
8Tait JF,Brown DS,Gibson DF,et al.Development and characterization of annexin V mutants with endogenous chelation sites for ^99mTc.Bioconjugate Chem,2000,11:918-925
9Levin G, Shirvan A, Grimberg H, et al. Novel fluorescence molecular imaging of chemotherapy - induced intestinal apoptnsis[ J ]. J Biomed Opt, 2009, 14(5) : 054019.
10Sun T, Tang GH, Tian H, et al. Positron emission tomography ima- ging of cardiomyocyte apoptosis with a novel molecule probe [ is F] FP -DPAZn2[J]. Oncotarget, 2015, 6( 31): 30579 -20591.
